Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Gossamer Bio (GOSS) Consolidated Net Income (2022 - 2025)

Historic Consolidated Net Income for Gossamer Bio (GOSS) over the last 4 years, with Q3 2025 value amounting to -$48.2 million.

  • Gossamer Bio's Consolidated Net Income fell 5654.64% to -$48.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$158.8 million, marking a year-over-year decrease of 11324.01%. This contributed to the annual value of -$56.5 million for FY2024, which is 6856.36% up from last year.
  • Gossamer Bio's Consolidated Net Income amounted to -$48.2 million in Q3 2025, which was down 5654.64% from -$38.3 million recorded in Q2 2025.
  • Over the past 5 years, Gossamer Bio's Consolidated Net Income peaked at $49.2 million during Q2 2024, and registered a low of -$59.0 million during Q3 2022.
  • Moreover, its 4-year median value for Consolidated Net Income was -$44.7 million (2024), whereas its average is -$39.8 million.
  • Its Consolidated Net Income has fluctuated over the past 5 years, first skyrocketed by 21585.09% in 2024, then crashed by 17774.01% in 2025.
  • Quarter analysis of 4 years shows Gossamer Bio's Consolidated Net Income stood at -$57.2 million in 2022, then rose by 15.85% to -$48.1 million in 2023, then surged by 31.4% to -$33.0 million in 2024, then tumbled by 46.0% to -$48.2 million in 2025.
  • Its Consolidated Net Income was -$48.2 million in Q3 2025, compared to -$38.3 million in Q2 2025 and -$39.3 million in Q1 2025.